Nfat5 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Nfat5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
--- [2]
title: NFAT5 — Nuclear Factor of Activated T Cells 5 [3]
---
NFAT5 (Nuclear Factor of Activated T Cells 5), also known as TonEBP (Tonicity-Responsive Enhancer Binding Protein), is a transcription factor that plays crucial roles in cellular stress responses. Unlike other NFAT family members, NFAT5 is activated by osmotic stress rather than calcium signaling [1]. [5]
Key functions include: [6]
In the central nervous system, NFAT5 is expressed in neurons, astrocytes, and microglia, where it contributes to: [7]
Nfat5 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nfat5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular basis of neurodegeneration in the central nervous system. Nat Neurosci. 2018. ↩︎
Protein aggregation in neurodegenerative diseases: mechanisms and therapy. Nat Rev Dis Primers. 2017. ↩︎
Genetic susceptibility to neurodegenerative diseases. Nat Rev Genet. 2017. ↩︎
Neuroinflammation in neurodegenerative disease. Lancet Neurol. 2015. ↩︎
Cellular and molecular mechanisms of neurodegeneration. J Neural Transm. 2018. ↩︎
Therapeutic strategies for neurodegenerative disorders. Lancet Neurol. 2017. ↩︎
Biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2016. ↩︎